ARTICLE | Clinical News
Sotagliflozin: Ph III inTandem2 data
January 27, 2017 9:06 PM UTC
Top-line data from the double-blind, international Phase III inTandem2 trial in 782 Type I diabetics inadequately controlled with insulin showed that once-daily 200 and 400 mg sotagliflozin given prio...